Evidence map›Paper›PMID 39988360›Full record

Trial reportGut2025

Multicentre randomised controlled trial of a self-assembling haemostatic gel to prevent delayed bleeding following endoscopic mucosal resection (PURPLE Trial).

Jan Drews, Markus Zachäus, Tobias Kleemann, Jörg Schirra, Oscar Cahyadi, Oliver Möschler, Christian Schulze, Ingo Steinbrück, Edris Wedi, Oliver Pech and 21 more

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Gut, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Hemostasis: Role of PuraStatWorld journal of gastrointestinal endoscopy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Jan DrewsGastroenterology, Heptology and Interventional Endoscopy, Asklepios Klinik Barmbek, Hamburg, Germany.ORCID http://orcid.org/0000-0003-1516-262X
Markus ZachäusGastroenterology, HELIOS Park-Klinikum Leipzig, Leipzig, Germany.
Tobias KleemannGastroenterology and Rheumatology, Carl-Thiem Hospital Cottbus, Cottbus, Germany.
Jörg SchirraInternal Medicine II, Ludwig Maximilian University, Munchen, Germany.
Oscar CahyadiInternal Medicine I, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Germany.
Oliver MöschlerInternal Medicine and Gastroenterology, Niels-Stensen-Kliniken GmbH, Osnabruck, Germany.
Christian SchulzeInternal Medicine I, Siloah Sankt Trudpert Klinikum, Pforzheim, Germany.
Ingo SteinbrückInternal Medicine and Gastroenterology, Evangelisches Diakoniekrankenhaus Freiburg, Freiburg, Germany.
Edris WediGastroenterology, Sana Klinikum Offenbach GmbH, Offenbach, Germany.
Oliver PechGastroenterology and Endoscopy, Krankenhaus Barmherzige Brüder Regensburg, Regensburg, Germany.
Tobias J WeismüllerGastroenterology and Hepatology, Vivantes-Humboldt-Klinikum, Berlin, Germany.
Armin KüllmerGastroenterology, University of Freiburg, Freiburg im Breisgau, Germany.
Mohamed AbdelhafezInternal Medicine II, Klinikum rechts der Isar der Technischen Universit, Munchen, Germany.
Jochen WedemeyerInternal Medicine, KRH Klinikum Robert Koch Gehrden, Gehrden, Germany.
Torsten BeynaGastroenterology, Evangelisches Krankenhaus Dusseldorf, Dusseldorf, Germany.ORCID http://orcid.org/0000-0003-3071-0428
Julian RiedelGastroenterology, HELIOS Park-Klinikum Leipzig, Leipzig, Germany.
Ulrich Paul HalmGastroenterology, HELIOS Park-Klinikum Leipzig, Leipzig, Germany.
Carola GütherGastroenterology and Rheumatology, Carl-Thiem Hospital Cottbus, Cottbus, Germany.
Riccardo VasapolliInternal Medicine II, Ludwig Maximilian University, Munchen, Germany.
Christian Torres ReyesInternal Medicine I, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Germany.ORCID http://orcid.org/0000-0001-9445-9514
Daniel R QuastInternal Medicine I, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Germany.
Oliver BachmannInternal Medicine I, Siloah Sankt Trudpert Klinikum, Pforzheim, Germany.
Erini DedonakiGastroenterology and Hepatology, Vivantes-Humboldt-Klinikum, Berlin, Germany.
Jörg UlrichInternal Medicine II, Klinikum rechts der Isar der Technischen Universit, Munchen, Germany.
Inna MarchukAsklepios Campus Hamburg, Semmelweis University, Hamburg, Germany.
Christina FrahmAsklepios Campus Hamburg, Semmelweis University, Hamburg, Germany.
Tanja SteffenAsklepios Campus Hamburg, Semmelweis University, Hamburg, Germany.
Peter WohlmuthAsklepios Campus Hamburg, Semmelweis University, Hamburg, Germany.
Torsten BundeGastroenterology, Heptology and Interventional Endoscopy, Asklepios Klinik Barmbek, Hamburg, Germany.
Nele GeßlerAsklepios Campus Hamburg, Semmelweis University, Hamburg, Germany.
Thomas von HahnGastroenterology, Heptology and Interventional Endoscopy, Asklepios Klinik Barmbek, Hamburg, Germany t.hahn@asklepios.com.ORCID http://orcid.org/0000-0002-1233-0379

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProphylactic application of a haemostatic gel to the resection field may be an easy way to prevent delayed bleeding, a frequent complication after endoscopic mucosal resection (EMR).

objectiveWe aimed to evaluate if the prophylactic application of a haemostatic gel to the resection field directly after EMR can reduce the rate of clinically significant delayed bleeding events.

designWe conducted a prospective randomised trial of patients undergoing hot-snare EMR of flat lesions in the duodenum (≥10 mm) and colorectum (≥20 mm) at 15 German centres. Prophylactic clip closure was not allowed, but selective clipping or coagulation could be used prior to randomisation to treat intraprocedural bleeding or for prophylactic closure of visible vessels. Patients were randomised to haemostatic gel application or no prophylaxis. The primary endpoint was delayed bleeding within 30 days.

resultsThe trial was stopped early due to futility after an interim analysis. The primary endpoint was analysed in 232 patients (208 colorectal, 26 duodenal). Both groups were comparable in age, sex, comorbidities and lesion characteristics. Preventive measures, such as selective clipping or coagulation, were applied prior to randomisation in 51.9% of cases, with no difference between groups. Delayed bleeding occurred in 14 cases (11.7%; 95% CI 7.1% to 18.6%) after Purastat and in 7 cases (6.3%; 95% CI 3.1% to 12.3%) in the control group (p=0.227), with no difference between colorectal and duodenal subgroups.

conclusionThe application of a haemostatic gel following EMR of large flat lesions in the duodenum and colorectum does not reduce the rate of delayed bleeding.

Indexed as

Colorectal NeoplasmsEndoscopic Mucosal ResectionGastrointestinal HemorrhageHemostaticsPostoperative HemorrhageAgedAged, 80 and overFemaleGelsHumansMaleMiddle AgedProspective StudiesTreatment OutcomeGelsHemostaticsBLEEDINGCLINICAL TRIALSCOLORECTAL ADENOMASENDOSCOPIC POLYPECTOMY

Identifiers

PMID39988360
PMCPMC12611798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.